VRTX Stock-Based Compensation

Vertex Pharmaceuticals · Stock-Based Compensation

VRTX logo

VRTX Stock-Based Compensation

Latest reported$689.10M
VRTX TTM Stock-Based Comp ($0.00 → $689.10M)
High-resolution chart · PNG

VRTX stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vertex Pharmaceuticals Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period endingStock-Based Compensation (USD)
689,099,999
686,199,999
685,899,999
696,099,999
685,800,000
672,700,000
698,500,000
739,300,000
685,600,000
650,700,000
581,200,000
484,100,000
488,800,000
483,400,000
491,300,000
498,408,000
465,804,000
456,526,000
441,400,000
419,819,000
416,362,000
428,929,000
429,461,000
424,025,000
409,906,000
382,404,000
360,489,000
347,841,000
347,953,000
340,702,000
325,047,000
321,506,000
309,744,000
299,890,000
290,736,000
274,416,000
261,855,000
251,215,000
237,705,000
223,269,000
227,794,000
229,113,000
231,025,000
228,761,000
209,163,000
188,346,000
177,542,000
158,530,000
143,702,000
142,608,000
127,303,000
123,499,000
122,374,000
115,580,000
114,285,000
125,902,000
127,121,000
127,167,000
126,751,000
120,780,000
114,563,000
106,495,000
97,676,000
85,605,000
81,828,000
84,020,000
86,722,000
131,566,000
110,158,000
81,432,000
71,057,000
13,072,000
13,072,000
20,796,000
20,044,000
59,181,000
59,181,000
51,457,000
47,262,000
15,655,000
16,570,000
16,570,000
9,880,000
2,350,000
1,435,000
1,435,000
778,000
778,000
778,000
778,000
799,000
799,000
799,000
799,000
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.